TACSTD2 and neoplasm: In this study, we applied a multiplex TMA strategy to profile the expression landscape of EGFR, EpCAM, TF, and TROP2 in TNBC specimens and explored associations between their expression and clinicopathological features, including tumor grade, tumor stage, HER2 status, and Ki-67 expression.